ARFIMA-GARCH modeling of HRV: Clinical application in acute brain injury by Almeida, R et al.
ARFIMA-GARCH modeling of HRV: clinical application in
Acute Brain Injury∗
Rute Almeida†
rbalmeid@fc.up.pt
Celeste Dias‡
mcdias@med.up.pt
Maria Eduarda Silva§
mesilva@fep.up.pt
Ana Paula Rocha¶
aprocha@fc.up.pt
March 2017
Abstract
In the last decade, several HRV based novel methodologies for describing and assessing heart
rate dynamics have been proposed in the literature with the aim of risk assessment. Such method-
ologies attempt to describe the non-linear and complex characteristics of HRV, and hereby the
focus is in two of these characteristics, namely long memory and heteroscedasticity with vari-
ance clustering. The ARFIMA-GARCH modeling considered here allows the quantification of
long range correlations and time-varying volatility. ARFIMA-GARCH HRV analysis is inte-
grated with multimodal brain monitoring in several acute cerebral phenomena such as intracranial
hypertension, decompressive craniectomy and brain death. The results indicate that ARFIMA-
GARCH modeling appears to reflect changes in Heart Rate Variability (HRV) dynamics related
both with the Acute Brain Injury (ABI) and the medical treatments effects.
1 INTRODUCTION
The combination of sympathetic nervous system and parasympathetic nervous system activation
defined as Autonomic Nervous System (ANS) tonus, is a function of both central mechanisms
and feedback from peripheral systems that might be impaired in critically ill patients with Acute
Brain Injury (ABI) [15, 9]. The incidence of ANS dysfunction after ABI is not exactly known,
but changes are thought to be related to the severity of injury, to clinical management and, more
importantly, seem to correlate independently with increased morbidity and mortality [55, 6, 34].
Heart rate variability (HRV) is currently defined by the fluctuating time between normal sinus
beats (RR intervals) [51], and indicates modulation of the heart rate by the ANS [46], barorecep-
tor function, thermoregulation, vasomotor tone and circadian rhythms [38]. HRV measurements
are easy to perform, non-invasive, and have good reproducibility, if used under standardized con-
ditions such as those set by the Task Force of the European Society of Cardiology and the North
American Society of Pacing and Electrophysiology in 1996 [49].
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Traditional HRV techniques are mostly based in the analysis of RR intervals either in time or
frequency domains. The resulting indexes include standard deviation measures, power spectral
measures in clinically relevant frequency bands, and ratio between low and high frequency activ-
ity (ANS branches balance). Since 1965 when Vallbona et al [50] linked HRV with the severity
of brain injury and brain death risk, several other authors reported correlations between HRV,
neuromonitoring variables and outcome after ABI [55, 6, 15, 13, 34, 33, 21, 47]. However, tradi-
tional approaches are unable to deal with high non stationarity of long HRV segments, specially
marked in critically ill patients. Therefore early studies were restricted to short intervals limiting
the development of dynamic prognostic tools in ABI [19].
In the last decades several new methodologies to analyse HRV have been proposed in the liter-
ature accompanied by their application in different physiological and clinical studies [38, 21, 44].
These methods comprehend, by a broad definition in [44], estimation of long-range correlation
and fractal scaling, quantifying short-term complexity, entropy and regularity measures, analysis
of chaotic behaviour with nonlinear dynamical systems. Alternatively, several authors proposed
model based approaches to HRV analysis which cope with the nonstationarity of the data. One
approach is time-variant AutoRegressive (AR) analysis using exponentially smoothed recursive
least squares estimation, with fixed and varying forgetting factors, [5, 41, 31]. Another approach
is based on the adaptive segmentation of the non stationary record into approximately stationary
records [36] which are usually modeled with short memory AR models. This procedure leads to
linear parametric models for the conditional mean which, however, do not capture the long range
correlations of HRV data. To overcome this drawback, Leite and co-authors [22] proposed the
use of Fractionally Integrated AutoRegressive Moving Average (ARFIMA) models, an extension
of the well-known AutoRegressive Moving Average (ARMA) models, to represent both short and
long term behaviours of HRV series. The authors use adaptive segmentation of 24-hour record-
ings of HRV to find that the long memory parameter changes with time and between day and night
periods. These findings were later corroborated by Baillie et al [3].
ARFIMA models describe the conditional mean of the data, however HRV exhibits also
changes in variance over time, with periods of large variability followed by periods of stabil-
ity, suggesting heteroscedasticity (varying variance). These volatility clustering phenomena may
be well described by conditional volatility models such as the Generalized AutoRegressive Condi-
tionally Heteroscedastic (GARCH), [8]. Consequently, Leite and co-authors [24, 25] considered
the joint modeling of long-memory and heteroscedasticity characteristics of HRV using fraction-
ally integrated ARFIMA models with GARCH innovations. In these works ARFIMA-GARCH
modeling is used to capture and remove long-range correlation and estimate conditional volatility
in 24-hour HRV recordings from Noltisalis database [45] and the database Is the Normal Heart
Rate Chaotic? 1 from Physionet [14], respectively, allowing to discriminate between health and
disease. A further empiric characteristic of HRV volatility is asymmetry in response to shocks.
Leite and co-authors [27, 42] used exponential GARCH (ARFIMA-EGARCH) models to capture
these effects and found that the parameters of the models are promising in differentiating health
and disease. Note that GARCH models were first applied in the HRV context to develop an HRV
based apnea screening tool [17], with the mean of the data described by a simple AR(1) process.
Rocha and co-authors [40] applied the ARFIMA-GARCH approach to the analysis of pediatric
patients with acute brain injury. In this study, the parameters for long-memory and conditional
variance estimated from cases with posterior confirmation of brain death (BD) differ significantly
from those estimated from survivors and seem able to contribute to characterize disease severity
in children with acute brain injury.
In spite of the dynamics of the ABI and the complexity of the Neurocritical Care Unit (NCCU)
management, HRV analysis is a valuable tool to investigate the sympathetic and parasympathetic
dysfunction of the ANS after ABI [47]. HRV has not been widely adopted by neurointensivists,
nevertheless its enormous potential for application at bedside after ABI.
In this chapter are considered some clinical conditions that frequently occur in the NCCU
1https://www.physionet.org/challenge/chaos/
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where ARFIMA-GARCH HRV analysis integrated with multimodal brain monitoring may help
clinicians to interpret or predict, in a more comprehensible way, acute cerebral phenomena such
as intracranial hypertension with: plateau waves, decompressive craniectomy and brain death.
2 ARFIMA-GARCH models
This section describes a class of models appropriate to characterize the persistence (long memory)
and nonlinear characteristics of RR series.
The characteristic of persistence, long-memory or long range dependence appears in many
natural phenomena and is characterized by slowly decaying serial correlations, or equivalently
by a spectrum with an hyperbolic behaviour at the origin, f (λ ) ∼ |λ |−2d . Long memory is thus
related to self-similar processes also known as fractals and the so called 1/ f noise. Heuris-
tic methods, such as the Detrended Fluctuation Analysis (DFA), the Rescaled Range (R/S) and
Rescaled Variance (R/V) are often used for assessing long memory in data but are mainly useful
for descriptive purposes rather than concrete statistical inference or model building. The alterna-
tive taken herein is to consider a model based approach with ARFIMA models (sometimes also
designated by FARIMA). These models extend the well known ARMA models for time series and
are, thus, able to model the short as well as the long memory of the data.
GARCH models were introduced in the literature to account for the following nonlinear be-
haviour of many data sets: heteroscedasticity in the conditional variance with clusters of volatility.
This same phenomena has been observed in RR series [24, 25]. To combine the persistence in
mean with conditional time-varying variance in a model based approach, ARFIMA models with
GARCH innovations are considered. The ARFIMA-GARCH models is a wide classe of models
which is able to cater for complex nonlinearities in dynamics of the data.
ARFIMA(p,d,0)-GARCH(1,1) models are defined as follows
φ(B)(1−B)dxt = εt , (1)
εt = σtzt , (2)
σ2t = Var(εt |Ft−1) = u0+ v1σ2t−1+u1ε2t−1 (3)
where B is the backward-shift operator, d ∈R is a real number, (1−B)d =
∞
∑
k=0
(
d
k
)
(−1)kBk is
the fractional difference operator, [4], φ(B) = 1−φ1B− ...−φpBp is a polynomial in B, u0 > 0,
u1,v1 ≥ 0, p∈N0, zt are independent and identically distributed random variables with zero mean
and unit variance and Ft denotes the history of the process up to time t. Equation (1) describes
the conditional mean of the process with serially uncorrelated residuals or shocks and is called
an ARFIMA(p,d,0) model [4]. Equations (2) and (3) describe the conditional variance of the
process and define a GARCH(1,1) model [8].
In equation (1) parameter d determines the long-term behaviour in mean2, whereas p and the
coefficients in φ(B) allow for the modeling of short-range properties. The model is stationary
for −0.5 < d < 0.5, nonstationary but mean reverting for 0.5 ≤ d < 1. Equation (3) describes
the dynamics of the conditional variance (volatility) of the process: σ2t is dependent on its own
lagged value and on the past squared shocks or residuals from the mean equation. Parameter u1
characterizes the short-range properties in volatility and parameter v1 characterizes persistence in
the volatility. The GARCH(1,1) model is second order stationary if v1+u1 < 1, [8]. Therefore the
ARFIMA(p,d,0)-GARCH(1,1) is stationary if −0.5 < d < 0.5, all the roots of φ(B) lie outside
the unit circle and v1+u1 < 1.
The spectral density function of a stationary ARFIMA(p,d,0) process is given by [16]
fω = f ∗ω |1− e−iω |−2d , −pi ≤ ω ≤ pi, (4)
2The long memory parameter is related to the Hurst coefficient, H = d+0.5, to the fractal dimension, D= 2−H and
to the slope of the (generalized) spectral density in the low frequency range by α = 2d.
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f ∗ω =
σ2ε
|φ(e−iω)|2 (5)
where
σ2ε = var(εt) =
u0
1− v1−u1 (6)
and f ∗ω is the spectral density of the AR(p) process. Since the autocorrelation function of a
GARCH(1,1) process is the same as that of white noise, [8], the spectral density function of
a stationary ARFIMA(p,d,0)-GARCH(1,1) process is given by equations (4) and (5) with σ2ε
defined by (6). For 0.5 ≤ d < 1 equation (4) corresponds to a pseudo-spectral density [18, 52],
since the process is nonstationary but mean reverting.
A final note regarding ARFIMA(p,d,0) models is due. The model may be extended to non-
stationary settings in which d = dLM+D> 1 with−0.5< dLM < 0.5 and D∈ {1,2, . . .}. The most
usual case occurs with D= 1, when the process is said to have a unit root: the ARFIMA(p,d,0)
is, then, used to model the increments of the series, that is the differences between consecutive
observations.
Given a time series x1, . . . ,xn, to estimate the parameters of an ARFIMA(p,d,0)-GARCH(1,1),
model proceed as follows [25]:
(i) estimate −0.5 < d < 0.5 using the semi-parametric local Whittle estimator [39];
(ii) define the filtered data yt = (1−B)dxt ;
(iii) estimate the AR(p)-GARCH(1,1) parameters in the filtered data yt by maximum likelihood.
The semi-parametric local Whittle estimator of the long memory, step (i), is an estimator in
the Fourier domain, and acknowledged in the literature for its statistical properties, efficiency and
asymptotic normality, and also easiness of implementation, [4]. Other estimators, such as the log-
wavelet regression estimator which is a semiparametric estimator in the wavelet domain, have the
disadvantage of complicated asymptotic distributions. It is worth noting that the standard error
of the estimator in (i) is quite large,
√
1/(4n0.8): for example, the standard error associated with
the estimate of d from a data set with n= 2000 observations is 0.024. Under the ARFIMA model
based approach it is also necessary determine the order p of the AR component of the model. This
is accomplished in step (iii) using Akaike Information Criterion, AIC, under maximum likelihood
estimation. The conditional heteroscedasticity in the series, that is the need for the GARCH
component, is assessed by the Ljung-Box test in the squared residuals, [28]. If the series does not
present heteroscedasticity then the final model is an ARFIMA(p,d,0). In any case, only models
with uncorrelated residuals, checked by the Ljung-Box test, are considered valid models.
To illustrate the use of ARFIMA(p,d,0)-GARCH(1,1) models in HRV data consider Figures
1 to 3, each one representing the analysis of a segment of the tachogram of a patient in inten-
sive care. Figure 1 represents in (a) the tachogram of a segment with 1571 beats and in (b)
the corresponding sample autocorrelation function (SACF) in black and the ACF of the best AR
model for the data in gray. The SACF shows a very slow decay indicating that the dependence
between distant observations is not negligible and thus displaying long memory characteristics.
An ARFIMA(p= 26,d = 0.19,0) model is fitted to this segment. The resulting residuals (εt ),
displayed in (c) exhibit little correlation, (d), indicating that the ARFIMA model is adequate to
explain the dynamics and conditional mean of the data. Also, the squared residuals in (e) exhibit
no significant autocorrelation in (f), indicating absence of time-varying conditional variance or
heteroscedasticity. These results are confirmed by the p-value < 0.001 of Ljung-Box test applied
to the squared residuals of ARFIMA. A similar analysis is depicted in Figure 2 but it is worth
noting that the SACF in (b) indicates a much stronger long-memory effect which is confirmed by
the value d = 0.61 estimated from the data. The last illustration is depicted in Figures 3. Once
again the SACF in (b) of the tachogram segment in (a) indicates the existence of long memory.
The residuals εt displayed in (c) and the corresponding SACF in (d), exhibit little correlation
indicating that the estimated ARFIMA(p = 19,d = 0.82,0) model is adequate to explain the dy-
namics and conditional mean of the data. However, the squared residuals in (e) exhibit significant
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autocorrelation in (f), indicating time-varying conditional variance or heteroscedasticity. These
results are confirmed by the p-value > 0.05 of Ljung-Box test applied to the squared residuals
of ARFIMA. Now, to model this effect a GARCH(1,1) model is entertained for the ARFIMA
residuals. The estimates for the parameters are u1 = 0.05, v1 = 0.94. The squared residuals from
the ARFIMA-GARCH(1,1) model and corresponding SACF, (g) and (h), indicate absence of het-
eroscedasticity. Finally, the volatility of this HRV segment is depicted in (i).
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Figure 1: (a) Tachogram (20 min segment with 1571 beats of RR series) with d = 0.19, (b) SACF (black)
and AR ACF (grey), (c) and (d) ARFIMA residuals and corresponding SACF, (e) and (f) squared residuals and
SACF. The horizontal lines (- -) show the 95% confidence limits for SACF.
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Figure 2: (a) Tachogram (20 min segment with 1569 beats of RR series) with d = 0.61, (b) SACF (black)
and AR ACF (grey), (c) and (d) ARFIMA residuals and corresponding SACF, (e) and (f) squared residuals and
SACF. The horizontal lines (- -) show the 95% confidence limits for SACF.
ARFIMA-GARCH models provide a set of parameters (φ1, . . . ,φp, p,d,u,v) that can be used
to describe linear and non-linear characteristics of HRV. The ARFIMA parameter d determines
the long-term behaviour in mean, while GARCH parameters u and v describe the non-linear be-
haviour of conditional time-variant variance. The order p and the coefficients φ1, . . . ,φp of the
AR component of the ARFIMA-GARCH model describe the short memory characteristics, as
the usual AR aproach to HRV modeling. Consequently as the ARFIMA-GARCH spectrum is
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Figure 3: (a) Tachogram (22 min segment with 1420 beats of RR series) with d = 0.82, (b) SACF (black)
and AR ACF (grey), (c) and (d) ARFIMA residuals and corresponding SACF, (e) and (f) squared residuals and
SACF, (g) and (h) ARFIMA-GARCH residuals and SACF, (i) conditional volatility. The horizontal lines (- -)
show the 95% confidence limits for SACF.
the same as that of ARFIMA, the spectral indexes extracted from the ARFIMA-GARCH model
provide the same information on HRV as that provided by AR models. The advantage is that the
estimation of d allows an individualized data based removal of the very low frequency component
and thus avoiding any additional filtering.
ARFIMA-GARCH models are applied in Section 4 to data from adult traumatic brain injury
patients described in the next section.
3 Data, pre-processing and HRV modeling
The data analysed in the remainder of this chapter regard a retrospective study of five adult severe
traumatic brain injury patients (TBI), admitted to a NCCU who developed intracranial hyper-
tension. The exclusion criteria were pregnancy and age (≤ 18 years). Standard management of
patients included sedation and analgesia with propofol and/or midazolam and fentanyl and nor-
moventilation. Intracranial Pressure (ICP) and Cerebral Perfusion Pressure (CPP) management
was achieved according to the NCCU protocol previously published [11], and approved by the
hospital Ethics Committee. The physiological variables continuously monitored included ECG at
250 Hz, heart rate (HR), arterial blood pressure (ABP), ICP, amplitude of ICP (AMP), CPP, End-
tidal CO2 (ETCO2), brain tissue oxygenation (pbtO2), cerebral blood flow (CBF) and cerebral
autoregulation (CAR) evaluated with cerebrovascular pressure reactivity index (PRx). Software
ICM+ R© was used to collect primary data and continuously record raw signals that were analysed
offline. Automatic ECG annotation was performed with a multi-scale wavelet-based ECG anno-
tator previously developed and validated [32] using MATLAB R© and BioSigBrowser [7] tools.
The RR series were defined as the time interval, in seconds, between consecutive QRS automatic
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locations; RR values admitted have a maximum of 3 sec and are within a 3/0.6745 tolerance on
the difference to Median Absolute Deviation, [54]. The series were divided into segments with
minimum 1024 and maximum 2048 consecutive beats and assumed to be sampled at the local
mean heart rate.
ARFIMA-GARCH modeling of each RR series segment, xt , described in Section 2 by steps
(i),(ii) and (iii) assumes that the segments xt are approximately stationary. However, since this is
not always the case, additional steps must be performed to ensure that the model are estimated over
stationary segments. First, the segment is tested for stationarity using the Augmented-Dickey-
Fuller test for unit roots, [30]. If there is a unit root, then D= 1, c.f. section 2 and the RR series
is differenced. This means that step (i) is performed over the differenced RR or, in other words,
the series of RR increments, ∆RR = xt −xt−1 . The resulting estimate d∆RRLM is expected to belong
to the interval ]− 0.5,0.5[ otherwise over-differencing may have occurred. However, in view of
the large standard error associated to the estimates for d, see section 2, a shorter, more robust
interval is considered for this purpose. Thus, if d∆RRLM >−0.45 then set d = 1+d∆RRLM in step (ii),
and proceed to step (iii). Otherwise, if d∆RRLM < −0.45 steps (i), (ii), (iii) are performed over
the RR series xt . Also, if there is no unit root, steps (i), (ii), (iii) are performed over the RR
series xt . The order of the AR(p) model is step (iii) is selected in the range 6 to 36 according AIC.
An RR segment is said to have a valid ARFIMA model if the residuals of the ARFIMA model
are uncorrelated, tested by Ljung-Box at 5% level of significance. Similarly, an RR segment
is said to have a valid ARFIMA-GARCH(1,1) model if the residuals of the ARFIMA model
are uncorrelated but its squared residuals are correlated, all tested by Ljung-Box at 5% level of
significance.
Finally and for comparison purposes, the RR segments are firstly detrended using smooth
priors (λ = 50), [48] and then modeled by an AR model with adequate order chosen by AIC.
For each fitted model, parametric HRV measures were obtained using spectral AR decom-
position [1] by assigning each pole contribution to the spectral band in which the pole is located
according to the standard fixed bands defined in [49]: low frequency (LF: 0.04-0.15 Hz) and high
frequency (0.15-1.4 Hz) bands, all frequencies in spectra (TP). LFn and HFn are measures, re-
spectively at LF and HF bands, normalized by power in the band above 0.04 Hz. Autonomic
balance B was obtained as LF/HF.
4 Clinical applications in Acute Brain Injury
ANS dysfunction in ABI leads to changes in HRV which appear to be particularly marked in pa-
tients subsequently declared with Brain Death (BD). It is well known that reduced HRV, assessed
in time, frequency and complexity, is a risk index after trauma for both morbidity and mortality
and an early predictor of BD. Previous studies on cardiovascular series variability indicate that the
derived indexes may provide an early complementary tool for time course prediction and prog-
nostic in critical illness [2, 43]. Although some authors have proposed HRV as an auxiliary tool
in trauma, it is not usually used in the clinical practice for ABI patients, nor considered as a deci-
sion support tool for the commencement of the proceeding for BD declaration [33, 43, 35]. This
work aims at illustrating the potential of ARFIMA-GARCH modeling of HRV, integrated with
multimodal brain monitoring, for helping clinicians to interpret or predict in a more comprehen-
sible way acute cerebral phenomena such as intracranial hypertension with: a) plateau waves, b)
decompressive craniectomy, c) brain death.
Plateau waves (PW) are sudden rises in ICP, up to 40-100 mmHg, lasting more than 5 min-
utes, terminating either spontaneously or in response to active treatment [10, 29]. Meanwhile
arterial blood pressure remains stable or varies modestly, as illustrated in Figure 4. Decompres-
sive craniectomy (DC) is a surgical option for managing refractory intracranial hypertension that
remains controversial. DC is efficacious in reducing ICP, as illustrated in Figure 5, by the re-
moval of a bone flap allowing brain volume expansion. The focus of current debate surrounds
identification of the subset of patients for whom it is appropriate to offer DC [20]. Intracranial
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hypertension may also evolve to brain death (BD) due to the absence of blood flow, zero flow
(ZF), in consequence of cerebral circulatory arrest leading to the complete and irreversible loss of
brain stem function [53] as illustrated in Figure 6.
Figure 4: Plateau wave (PW) documentation with multimodal brain monitoring using intracranial pressure
(ICP), mean arterial blood pressure (ABP), cerebral perfusion pressure (CPP), brain tissue oxygenation pressure
(pbtO2), cerebral blood flow (CBF) and cerebral autoregulation (CAR) evaluation with pressure reactivity index
(PRx). During PW while ICP increases, CPP, pbtO2 and CBF decreases along with impairment of CAR (PRx
>0.3). After PW, CPP and PRx recover but pbtO2 and CBF increase because of hyperaemic response after
ischemia.
Figure 5: Multimodal brain monitoring changes before and after decompressive craniectomy represented by
mean arterial blood pressure (ABP), cerebral perfusion pressure (CPP), intracranial pressure (ICP), amplitude
of ICP (AMP), cerebrovascular pressure reactivity (PRx) and endtidal carbon dioxide (ETCO2).
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Figure 6: Multimodal brain monitoring documentation of the evolution to irreversible zero flow and brain
death. While intracranial pressure (ICP) increases and cerebral perfusion pressure (CPP) compromises, cerebral
blood flow (CBF) and brain tissue oxygen pressure (pbtO2) decline to ischemic thresholds. Arterial blood
pressure (ABP) remains almost constant. Cerebrovascular reactivity pressure (PRx) in the lower panel becomes
a solid line clearly meaning severe impairment of cerebral autoregulation (CAR).
The clinical examples presented in this section regard five adult patients with severe traumatic
brain injury. All patients, as already mentioned, developed intracranial hypertension. Patient P1 is
a noteworthy example of intracranial hypertension with plateau waves due to the huge number of
occurrences, along with a good response to osmotherapy with hypertonic saline medical treatment
thus avoiding DC. Four patients, hereafter designated by P2 to P5 were submitted to DC. Two of
these, P2 and P3 survived with good outcome while the other two, P4 and P5, evolved to BD.
The results of analysing a total of 2123 segments across all available data from the five patients
are summarized in Table 1. The low signal quality, with many corrupted excerpts, typically found
in intensive care recordings, is the cause of the reduced number of segments per day. Firstly, note
that not only the percentage of segments fitted with ARFIMA models is higher but also the median
length of those segments is larger. Moreover, the order of the ARFIMA models is relevantly
lower, with only approximately half of the segments needing an order higher than p= 30. These
findings indicate that the ARFIMA model inherent detrending is superior to the current advanced
HRV detrending techniques using smooth priors, leading to a better adjustment to each patient.
Thus ARFIMA-GARCH modeling is advantageous to describe HRV dynamics.
To analyse the effect of PW in the dynamics of HRV consider the occurrence of four plateau
waves with minimum duration of approximately 9 minutes (events) for patient P1. For each event
two segments are considered: the period of time with ICP >40 mmHg, designated by during
PW and 1024 beats after ICP normalized below 20 mmHg, designated by after PW. The results
are summarized in Table 2. In segment during PW, d > 0.54 and the GARCH parameters u,v
satisfy u+v> 0.9, while in segment after PW, d decreases to values below 0.33 in the first three
events and d = 0.47 in the 4th event. The volatility, measured by u+ v also decreases to low
values, u+ v < 0.65, in the first three events, with two of them presenting absence of volatility,
u+ v = 0. The 4th event, presenting the higher values for long memory d = 0.47 and volatility
u+ v = 0.98, has the particularity of corresponding to a spontaneous reversion of ICP without
osmotherapy. These findings suggest the hypothesis that hypertonic saline not only decreases ICP
but also affects the dynamics of HRV in terms of conditional mean and conditional variance. In
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Patients
P1 P2 P3 P4 P5 Overall
Monitorization (approximate length) 21 days 7 days 16 days 12 days 10 days 66 days
Total number of segments 672 247 405 265 534 2123
AR 60% 53% 56% 48% 49% 54%
% segments with valid models
ARFIMA 86% 95% 88% 84% 87% 87%
AR 2162.5 1893 1776.5 1679 2870 2016
Median length (beats)
ARFIMA 2926.5 3047 2672 2424.5 4096 3031
AR 36 36 35 36 36
median order
ARFIMA 29 27 31 31 30
% models with AR 90% 86% 82% 88% 81% 85%
maximum order chosen above 30
ARFIMA 46% 40% 51% 51% 47% 47%
Table 1: Features resulting from the modeling of RR series segments , during the whole period of
monitoring, of patients P1 to P5 with AR models and ARFIMA-GARCH models.
during PW after PW
Event d u v d u v
1 0.55 0.07 0.9 0.33 0 0
2 0.54 0.45 0.54 0.23 0.20 0.44
3 0.78 0.11 0.82 0.30 0 0
4 0.82 0.07 0.09 0.47 0.03 0.95
Table 2: ARFIMA-GARCH model parameters estimates in RR segments during PW and after PW
plateau waves with minimum duration of approximately 9 minutes (events).
fact, Dias and co-authors [11] have shown that the first effect of hypertonic saline administration
is an increase of cerebral blood flow with reduction of cerebral vascular resistance while ABP
is minimally affected. These effects, although small, may nevertheless be sufficient to induce
variations in HRV dynamics.
As mentioned above, the management of the refractory intracranial hypertension of patients
P2 to P5 involved a surgical approach by DC. The immediate effect of the surgical procedure in
the HRV dynamics was studied by comparing the parametric HRV measures over the admissible
models in the periods of 24h before (PRE) and after (POST) DC.
Figure 7 summarizes the distributions of TP, B, LFn and HFn for each patient in PRE and
POST decompressive cranietomy, calculated over the segments described in Table 3. In the upper
panels, the represented values were obtained from segments for which adequate AR (left boxplots)
and ARFIMA-GARCH (right boxplots) models were found. Differences both in median values
and dispersion are observable, in particular for LFn and B, both depending on LF. These findings
indicate that the detrending strategies (smooth prior detrending and long-memory filtering) have
impact in the spectral measures.
Note that the percentage of segments fitted with ARFIMA models is much higher and also the
median length of those segments is larger than those fitted with AR models. This fact prompts the
10
Patients
P2 P3 P4 P5
PRE POS PRE POS PRE POS PRE POS
Total number of segments 10 30 18 28 21 15 20 27
AR 50% 77% 44% 37% 81% 33% 65% 15%
% segments with valid models
ARFIMA 100% 100% 100% 86% 100% 100% 95% 96%
AR 1877 1653 2456.5 1553 1857 1634 2680 4096
Median length (beats)
ARFIMA 3043.5 2277 3896 2994.5 2215 3000 3358 4096
Table 3: Features resulting from modeling RR series segments of patients P2 to P5, in the periods of
24h before (PRE) and after (POS) DC, with AR and ARFIMA-GARCH models.
study of the spectral measures obtained for all segments for which ARFIMA model was estimated,
which are represented in the lower panels of figure 7. Globally, TP decreases after DC while B
stays at a comparable level. Regarding the two traditional bands, HFn decreases and LFn increases
except in P2. As a matter of fact, the absolute measures HF and LF decrease for all patients
except LF in P4. The less marked reduction in LF may be explained by the sustained need of
hemodynamic support managed with noradrenaline infusion according to NCCU protocol [11].
The changes of these spectral measures may be related to the decrease of intracranial pressure
expected after DC [12]. In spite of absence of relevant differences in the median of B with
DC, the dispersion (evaluated by interquartile range) increased. In a recent study by Dias et al
[12] over 9 patients submitted to DC (including the four patients P2-P5) the correlation between
nonparametric based B and ICP was studied. A positive significant correlation of 0.4 was found
in the 12h immediately preceding DC, becoming negligible and non significant in the post-DC
period.
For patients P4 and P5 who evolved to BD, the time of ZF, was documented c.f. Figure 6. It is
then possible to study retrospectively HRV dynamics in 24h periods from the monitoring restore
time after DC to ZF and after ZF. In addition to the expected reduced HRV, ARFIMA-GARCH
modeling indicates also less heteroscedasticity in BD, measured by the percentage of segments in
each 24h with u+ v ≥ 0.65, Figure 8. Note that there are the two values for patient P5 in day 6
resulting from the fact that ZF occurred within that 24h period. The marked reduction between the
two values reflects an immediate effect of ZF. Thus, ARFIMA-GARCH models allow to notice
that heteroscedasticity decreases simultaneously with the irreversible compromising of cerebral
perfusion pressure.
In summary, ARFIMA-GARCH modeling allows the quantification of long range correlations,
d, and volatility, u and v, which appear to reflect changes in HRV dynamics related both with the
acute brain lesion and the medical treatments effects.
5 Final Comments
The last decade has witnessed an increase of interest in the characterization of complexity and
nonlinearity in HRV with the aim of risk assessment. Here two specific complex/nonlinear char-
acteristics of HRV, long memory and time-varying variance, are considered from a model based
parametric point of view. Concerning long memory, several studies in the literature [23, 26], and
references there included, indicate that the application of heuristic approaches such as DFA, lead
to the same information on HRV. However, the model based ARFIMA approach has the advan-
tage of allowing the design of individualized filters and simultaneously the obtention of clinically
interpretable measures such as low and high frequency components in HRV.
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Figure 7: Box plot of spectral measures over TP, B, LFn and HFn for each patient in pre-DC and post-DC: in
the upper panel first box plot for each case correspond to AR models and the second to ARFIMA models.
The potential of HRV analysis as a tool to assess the sympathetic and parasympathetic dys-
function of the ANS after ABI has not been fully investigated yet, although Norris et al [37]
suggested that HRV could be used to predict the outcome in critically injured patients as one of
a set of new vital signs. The parametric ARFIMA-GARCH approach advocated in this study
provides new measures to describe the individual patient HRV dynamics, which may be partic-
ularly relevant to clinicians who manage critically ill patients with complex medical conditions
that change rapidly and sometimes unpredictably. Further studies are warranted to fully appraise
ARFIMA-GARCH modeling of HRV in acute brain injury.
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Figure 8: Percentage of models with u+ v≥ 0.65 for BD patients, P4 and P5. Dark marks correspond to time
after zero flow (ZF).
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